Page last updated: 2024-08-21

metylperon and Dementia

metylperon has been researched along with Dementia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doblhammer, G; Eriksdotter, M; Garcia-Ptacek, S; Haenisch, B; Johnell, K; Nerius, M1
Gutzmann, H; Kanowski, S; Khan-Boluki, J; Kühl, KP1

Trials

1 trial(s) available for metylperon and Dementia

ArticleYear
Measuring the efficacy of psychopharmacological treatment of psychomotoric restlessness in dementia: clinical evaluation of tiapride.
    Pharmacopsychiatry, 1997, Volume: 30, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Butyrophenones; Dementia; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation; Substance Withdrawal Syndrome; Tiapamil Hydrochloride

1997

Other Studies

1 other study(ies) available for metylperon and Dementia

ArticleYear
The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2018, 09-11, Volume: 73, Issue:10

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Butyrophenones; Cohort Studies; Dementia; Female; Germany; Haloperidol; Homes for the Aged; Humans; Institutionalization; Long-Term Care; Male; Middle Aged; Nursing Homes; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone

2018